Wolf M, Kettyle E, Sandler L, Ecker J L, Roberts J, Thadhani R
Renal Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Obstet Gynecol. 2001 Nov;98(5 Pt 1):757-62. doi: 10.1016/s0029-7844(01)01551-4.
Systemic inflammation might contribute to the pathogenesis of preeclampsia. In addition, the association between obesity and inflammation in preeclampsia has not been examined in detail. We determined whether first-trimester elevation of serum C-reactive protein, an index of systemic inflammation, was associated with preeclampsia.
We conducted a prospective, nested case-control study among women enrolled in the Massachusetts General Hospital Obstetrical Maternal Study cohort. High-resolution C-reactive protein assays were performed on first-trimester (11 +/- 2 weeks' gestation) serum samples in 40 women in whom preeclampsia developed (blood pressure [BP] greater than 140/90 mmHg, and proteinuria, either 2+ or more by dipstick or greater than 300 mg per 24 hours), and in 80 matched controls. This sample size had greater than 80% power to detect a difference in C-reactive protein levels between cases and controls. We used nonparametric tests to compare C-reactive protein levels and conditional logistic regression to control for confounding variables.
First-trimester C-reactive protein levels were significantly higher among women in whom preeclampsia subsequently developed compared with controls (4.6 compared with 2.3 mg/L, P =.04). When women were subdivided into C-reactive protein quartiles, the odds ratio (OR) of being in the highest quartile of C-reactive protein was 3.2 (95% confidence interval [CI] 1.1, 9.3, P =.02) among cases of preeclampsia compared with controls. When body mass index (BMI) was added to the multivariable model, the highest quartile of C-reactive protein was no longer associated with increased risk of preeclampsia (OR 1.1, 95% CI.3, 4.3, P =.94). In the same model without BMI, the highest quartile of C-reactive protein was associated with increased risk of preeclampsia (OR 3.5, 95% CI 1.3, 9.5, P =.01).
In women with preeclampsia, there was evidence of increased systemic inflammation in the first trimester. Inflammation might be part of a causal pathway through which obesity predisposes to preeclampsia.
全身炎症可能参与子痫前期的发病机制。此外,肥胖与子痫前期炎症之间的关联尚未得到详细研究。我们确定孕早期血清C反应蛋白(一种全身炎症指标)升高是否与子痫前期有关。
我们在参与麻省总医院产科孕产妇研究队列的女性中进行了一项前瞻性巢式病例对照研究。对40例发生子痫前期(血压[BP]大于140/90 mmHg,蛋白尿,试纸检测为2+或更高或每24小时大于300 mg)的女性以及80例匹配对照的孕早期(妊娠11±2周)血清样本进行了高分辨率C反应蛋白检测。该样本量有超过80%的把握度检测病例组和对照组之间C反应蛋白水平的差异。我们使用非参数检验比较C反应蛋白水平,并使用条件逻辑回归来控制混杂变量。
与对照组相比,随后发生子痫前期的女性孕早期C反应蛋白水平显著更高(分别为4.6 mg/L和2.3 mg/L,P = 0.04)。当将女性按C反应蛋白四分位数分组时,子痫前期病例组中处于C反应蛋白最高四分位数的比值比(OR)为3.2(95%置信区间[CI] 1.1, 9.3, P = 0.02),与对照组相比。当将体重指数(BMI)纳入多变量模型时,C反应蛋白最高四分位数与子痫前期风险增加不再相关(OR 1.1, 95% CI 0.3, 4.3, P = 0.94)。在没有BMI的同一模型中,C反应蛋白最高四分位数与子痫前期风险增加相关(OR 3.5, 95% CI 1.3, 9.5, P = 0.01)。
在子痫前期女性中,有证据表明孕早期全身炎症增加。炎症可能是肥胖易患子痫前期的因果途径的一部分。